Cresco Labs (CRLBF) Enterprise Value (2019 - 2026)
Cresco Labs (CRLBF) posted Enterprise Value of -$155.4 million for Q1 2026, up 13.21% on a QoQ basis from -$179.0 million in Q4 2025, and down 72.86% year-over-year from -$572.6 million in Q1 2025.
Cresco Labs (CRLBF) Enterprise Value (2019 - 2026) Analysis & Trends
Cresco Labs' Enterprise Value history runs 8 years deep, the most recent figure standing at -$155.4 million for Q1 2026.
- Quarterly Enterprise Value fell 72.86% year-over-year to -$155.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$155.4 million (down 58.02% YoY) and the FY2025 annual result came in at -$179.0 million, down 98.67% from the prior year.
- Enterprise Value was -$155.4 million for Q1 2026 at Cresco Labs, up from -$179.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$15.9 million in Q2 2022 and bottomed at -$209.1 million in Q2 2024.
- A 5-year average of -$104.3 million and a median of -$89.9 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 88.87% — and 2023, when it sank 379.69%.
- Cresco Labs' Enterprise Value stood at -$39.4 million in 2022, then slumped by 372.98% to -$186.1 million in 2023, then surged by 51.59% to -$90.1 million in 2024, then tumbled by 98.67% to -$179.0 million in 2025, then climbed by 13.21% to -$155.4 million in 2026.
- Business Quant data shows CRLBF's Enterprise Value at -$155.4 million in Q1 2026, -$179.0 million in Q4 2025, and -$121.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -155.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155.39 Mn |
| Dec 31, 2025 | -179.03 Mn |
| Sep 30, 2025 | -121.46 Mn |
| Jun 30, 2025 | -86.71 Mn |
| Mar 31, 2025 | -89.89 Mn |
| Dec 31, 2024 | -90.12 Mn |
| Sep 30, 2024 | -94.78 Mn |
| Jun 30, 2024 | -209.11 Mn |
| Mar 31, 2024 | -85.08 Mn |
| Dec 31, 2023 | -186.15 Mn |
| Sep 30, 2023 | -80.43 Mn |
| Jun 30, 2023 | -76.39 Mn |
| Mar 31, 2023 | -54.04 Mn |
| Dec 31, 2022 | -39.36 Mn |
| Sep 30, 2022 | -17.87 Mn |
| Jun 30, 2022 | -15.93 Mn |
| Mar 31, 2022 | -191.57 Mn |
| Dec 31, 2021 | 37.06 Mn |
| Sep 30, 2021 | -160.51 Mn |
| Jun 30, 2021 | -135.23 Mn |